$115 Million is the total value of New England Research & Management, Inc.'s 168 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 4.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UL | Unilevercs | $1,133,000 | -7.6% | 27,050 | 0.0% | 0.99% | -9.9% | |
| TKR | Timkencs | $1,086,000 | -37.6% | 25,630 | 0.0% | 0.95% | -39.1% | |
| T | A T & Tcs | $840,000 | -0.4% | 23,835 | 0.0% | 0.73% | -2.9% | |
| STI | SunTrust Bankscs | $830,000 | -5.0% | 21,825 | 0.0% | 0.72% | -7.4% | |
| NKE | Nike Inc Class Bcs | $830,000 | +15.1% | 9,300 | 0.0% | 0.72% | +12.2% | |
| ABT | Abbott Labscs | $782,000 | +1.7% | 18,808 | 0.0% | 0.68% | -0.9% | |
| BRKB | Berkshire Hathaway Bcs | $735,000 | +9.1% | 5,323 | 0.0% | 0.64% | +6.3% | |
| MMM | 3M Corp.cs | $625,000 | -1.0% | 4,408 | 0.0% | 0.55% | -3.4% | |
| AGU | Agriumcs | $623,000 | -2.8% | 7,000 | 0.0% | 0.54% | -5.2% | |
| SU | Suncor Energycs | $495,000 | -15.2% | 13,700 | 0.0% | 0.43% | -17.4% | |
| TROW | T. R. Pricecs | $482,000 | -7.1% | 6,150 | 0.0% | 0.42% | -9.5% | |
| PEP | Pepsicocs | $410,000 | +4.3% | 4,400 | 0.0% | 0.36% | +1.7% | |
| AAPL | Apple Computercs | $410,000 | +8.5% | 4,067 | 0.0% | 0.36% | +5.6% | |
| COH | Coach, Inc.cs | $358,000 | +4.4% | 10,040 | 0.0% | 0.31% | +2.0% | |
| SIAL | Sigma-Aldrichcs | $295,000 | +34.1% | 2,168 | 0.0% | 0.26% | +31.0% | |
| STTPRCCL | State Street Preferred Ccs | $274,000 | -0.4% | 11,900 | 0.0% | 0.24% | -2.8% | |
| HSBCPRA | HSBC Holdings Pfd Acs | $270,000 | -0.7% | 10,750 | 0.0% | 0.24% | -3.3% | |
| BMR | Biomed Realty Trustcs | $266,000 | -7.3% | 13,150 | 0.0% | 0.23% | -9.7% | |
| GWR | Genesee and Wyomingcs | $250,000 | -9.4% | 2,625 | 0.0% | 0.22% | -11.7% | |
| PVTB | Private Bancorpcs | $238,000 | +3.0% | 7,950 | 0.0% | 0.21% | +0.5% | |
| TGT | Targetcs | $229,000 | +8.0% | 3,650 | 0.0% | 0.20% | +5.3% | |
| AZN | Astrazenecacs | $218,000 | -4.0% | 3,050 | 0.0% | 0.19% | -6.4% | |
| The FRS Companycs | $0 | – | 114,324 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-10-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Church and Dwight | 40 | Q3 2023 | 5.1% |
| Johnson & Johnson | 40 | Q3 2023 | 3.9% |
| Cisco Systems | 40 | Q3 2023 | 3.4% |
| Kimberly-Clark | 40 | Q3 2023 | 2.9% |
| Apple Computer | 40 | Q3 2023 | 3.4% |
| Exxon Mobil | 40 | Q3 2023 | 2.9% |
| Pfizer | 40 | Q3 2023 | 2.3% |
| Microsoft | 40 | Q3 2023 | 2.8% |
| CSX Corp | 40 | Q3 2023 | 2.2% |
| Merck | 40 | Q3 2023 | 1.9% |
View New England Research & Management, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-16 |
| 13F-HR | 2024-02-06 |
| 13F-HR | 2023-10-10 |
| 13F-HR | 2023-07-05 |
| 13F-HR | 2023-04-06 |
| 13F-HR | 2023-01-09 |
| 13F-HR | 2022-10-06 |
| 13F-HR | 2022-07-20 |
| 13F-HR | 2022-04-20 |
| 13F-HR | 2022-01-05 |
View New England Research & Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.